|
Diabetes, Vol 25, Issue 4 275-282, Copyright © 1976 by American Diabetes Association
Glucagon secretion from the perfused pancreas of streptozotocin-treated rats
GC Weir, SD Knowlton, RF Atkins, KX McKennan and DB Martin
One hour following intravenous streptozotocin, rat pancreases were perfused
in situ, and , in contrast to saline-injected controls a marked decrease of
insulin secretion was observed. In these streptozotocin-treated animals,
baseline glucagon secretion was enhanced when the perfusate glucose
concentration was either 80 mg./100 ml. or 300 mg./100 ml. In addition
there was hypersecretion of glucagon in response to arginine. Exogenous
insulin (20,000 muU./ml.) could suppress glucagon secretion when endogenous
secretion was plentiful. Baseline and arginine-stimulated glucagon
secretion of the streptozotocin treated animals was not suppressed by large
amounts of glucose and insulin to the degree seen in control animals. The
glucagon rise in response to an abrupt fall of glucose from 80 mg./100 ml.
to 25 mg./100 ml. was not significantly higher in the control group than in
the streptozotocin group. The results seen with epinephrine were in sharp
contrast to those found with arginine. Epinephrine-stimulated glucagon
secretion was not enhanced in the streptozotocin group. In addition,
epinephrine-induced secretion could be suppressed by exogenous insulin in
both the control and streptozotocin groups. The differences may be
secondary to differences of endogenous insulin secretion. The present
results are compatible with the hypothesis that local insulin secretion can
exert a significant suppressive effect upon the alpha cell and that the
inhibition of glucagon secretion by glucose is partially mediated by this
mechanism. Furthermore, anomalous local insulin secretion may contribute to
the abnormal glucagon secretion of diabetes mellitus.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. D. Wideman, S. D. Covey, G. C. Webb, D. J. Drucker, and T. J. Kieffer
A Switch From Prohormone Convertase (PC)-2 to PC1/3 Expression in Transplanted {alpha}-Cells Is Accompanied by Differential Processing of Proglucagon and Improved Glucose Homeostasis in Mice
Diabetes,
November 1, 2007;
56(11):
2744 - 2752.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Gromada, I. Franklin, and C. B. Wollheim
{alpha}-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma Remains
Endocr. Rev.,
February 1, 2007;
28(1):
84 - 116.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Shiota, J. V. Rocheleau, M. Shiota, D. W. Piston, and M. A. Magnuson
Impaired glucagon secretory responses in mice lacking the type 1 sulfonylurea receptor
Am J Physiol Endocrinol Metab,
October 1, 2005;
289(4):
E570 - E577.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Ravier and G. A. Rutter
Glucose or Insulin, but not Zinc Ions, Inhibit Glucagon Secretion From Mouse Pancreatic {alpha}-Cells
Diabetes,
June 1, 2005;
54(6):
1789 - 1797.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Franklin, J. Gromada, A. Gjinovci, S. Theander, and C. B. Wollheim
{beta}-Cell Secretory Products Activate {alpha}-Cell ATP-Dependent Potassium Channels to Inhibit Glucagon Release
Diabetes,
June 1, 2005;
54(6):
1808 - 1815.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Hope, P. O. T. Tran, H. Zhou, E. Oseid, E. Leroy, and R. P. Robertson
Regulation of {alpha}-Cell Function by the {beta}-Cell in Isolated Human and Rat Islets Deprived of Glucose: the "Switch-off" Hypothesis
Diabetes,
June 1, 2004;
53(6):
1488 - 1495.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Omer, V. F. Duvivier-Kali, W. Aschenbach, V. Tchipashvili, L. J. Goodyear, and G. C. Weir
Exercise Induces Hypoglycemia in Rats With Islet Transplantation
Diabetes,
February 1, 2004;
53(2):
360 - 365.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Paris, C. Bernard-Kargar, M.-F. Berthault, L. Bouwens, and A. Ktorza
Specific and Combined Effects of Insulin and Glucose on Functional Pancreatic {beta}-Cell Mass in Vivo in Adult Rats
Endocrinology,
June 1, 2003;
144(6):
2717 - 2727.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Banarer, V. P. McGregor, and P. E. Cryer
Intraislet Hyperinsulinemia Prevents the Glucagon Response to Hypoglycemia Despite an Intact Autonomic Response
Diabetes,
April 1, 2002;
51(4):
958 - 965.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-J. Liu, Y. Nakagawa, and T. Ohzeki
Gene Expression of 11ß-Hydroxysteroid Dehydrogenase Type 1 and Type 2 in the Kidneys of Insulin-Dependent Diabetic Rats
Hypertension,
March 1, 1998;
31(3):
885 - 889.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1976 by the American Diabetes Association.
|
|
| |
|